stoxline Quote Chart Rank Option Currency Glossary
  
Biotricity, Inc. (BTCY)
1.48  0.13 (9.63%)    03-28 16:00
Open: 1.37
High: 1.55
Volume: 25,742
  
Pre. Close: 1.35
Low: 1.345
Market Cap: 14(M)
Technical analysis
2024-03-28 4:50:13 PM
Short term     
Mid term     
Targets 6-month :  1.95 1-year :  2.27
Resists First :  1.66 Second :  1.95
Pivot price 1.39
Supports First :  1.13 Second :  0.8
MAs MA(5) :  1.36 MA(20) :  1.3
MA(100) :  1.04 MA(250) :  1.36
MACD MACD :  0 Signal :  0.1
%K %D K(14,3) :  59.6 D(3) :  55.9
RSI RSI(14): 59.9
52-week High :  3.78 Low :  0.43
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BTCY ] has closed below upper band by 31.8%. Bollinger Bands are 8.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.55 - 1.56 1.56 - 1.57
Low: 1.33 - 1.34 1.34 - 1.34
Close: 1.47 - 1.48 1.48 - 1.49
Company Description

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Headline News

Thu, 28 Mar 2024
Biotricity expands reach to 90% of US hospitals By Investing.com - Investing.com

Tue, 26 Mar 2024
Should You Hold Biotricity Inc (BTCY) in Medical Devices Industry? - InvestorsObserver

Fri, 22 Mar 2024
Is Biotricity Inc (BTCY) Stock a Good Value Friday? - InvestorsObserver

Thu, 21 Mar 2024
Biotricity, Inc. | Nation and World | corsicanadailysun.com - Corsicana Daily Sun

Thu, 21 Mar 2024
Biotricity Partners with Health Aid Africa to Provide Complementary Heart Health Screenings at Allegiant Stadium Concert - The Caledonian-Record

Fri, 08 Mar 2024
HC Wainwright Analysts Lift Earnings Estimates for Biotricity, Inc. (NASDAQ:BTCY) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 9 (M)
Shares Float 8 (M)
Held by Insiders 14.8 (%)
Held by Institutions 3.9 (%)
Shares Short 89 (K)
Shares Short P.Month 111 (K)
Stock Financials
EPS -1.75
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.96
Profit Margin -125.5 %
Operating Margin -43.2 %
Return on Assets (ttm) -95.2 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 20.8 %
Gross Profit (p.s.) 0
Sales Per Share 1.25
EBITDA (p.s.) -1
Qtrly Earnings Growth 0 %
Operating Cash Flow -7 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.85
PEG Ratio 0
Price to Book value -0.51
Price to Sales 1.17
Price to Cash Flow -1.85
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android